Multimorbidity is a massive topic for the AKT because it’s basically the bread and butter of UK primary care. It's not just about managing individual diseases; it's about managing the patient who has all of them at once, which often leads to the "polypharmacy puzzle."

To get us started, I'll pull up some high-yield lessons that cover the essentials of multimorbidity and how to handle complex medication regimens.

Managing multimorbidity in the UK follows the NICE NG56 guidelines, which shift the focus from "disease-specific" to "patient-centered" care. The goal is to reduce treatment burden and improve quality of life, especially when the interaction between multiple conditions or their treatments becomes problematic.

I'll search for a clinical flowchart or table that outlines the management steps for these complex patients.

While we often think of polypharmacy as "too many pills," it's important to distinguish between appropriate polypharmacy (where the benefits of multiple evidence-based drugs outweigh the risks) and problematic polypharmacy (where the cumulative side effects or treatment burden reduce the patient's quality of life).

For the AKT, you should be familiar with the 7-step process for medication review in multimorbidity. I've summarized it in the table below:

When it comes to deprescribing, the STOPP/START criteria are your best friends in the AKT. They help you identify medications that are potentially inappropriate for older people.

• STOPP (Screening Tool of Older Persons' Prescriptions): Identifies drugs that should be stopped because the risks (like falls, confusion, or GI bleeds) outweigh the benefits.
  • Example: Long-term PPIs (risk of C. diff and fractures) or Benzodiazepines (risk of falls and cognitive decline).
• START (Screening Tool to Alert to Right Treatment): Identifies evidence-based medications that are missing from a patient's regimen.
  • Example: Bisphosphonates in a patient with a high FRAX score or ACE inhibitors in heart failure.

Management Strategy for Multimorbidity (NICE NG56):

1. Identify patients: Use clinical judgment or tools like the Electronic Frailty Index (eFI).
2. Assessment: Focus on the patient's priorities. If they care more about mobility than their HbA1c, you might relax their diabetes targets to avoid hypoglycemia.
3. Review: Use the 7-step process we just looked at.
4. Documentation: Ensure the patient has a clear, updated medication list and a management plan they understand.

It’s all about finding that balance between evidence-based medicine and what actually makes sense for the person sitting in front of you!